Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
L'Europe
EU
Acticor Biotech (ALACT)
Acticor Biotech (ALACT) Actualités

ALACT

Acticor Biotech (ALACT)

Acticor Biotech

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:EU:ALACT

1

Date	Heure	Source	Titre	Symbole	Société
03/06/2024	18h15	GlobeNewswire Inc.	Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies	EU:ALACT	Acticor Biotech
07/02/2024	18h00	GlobeNewswire Inc.	The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack	EU:ALACT	Acticor Biotech
07/11/2023	10h34	GlobeNewswire Inc.	Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in stroke	EU:ALACT	Acticor Biotech
14/09/2023	18h15	GlobeNewswire Inc.	Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatment of stroke	EU:ALACT	Acticor Biotech

Showing the most relevant articles for your search:EU:ALACT

1

Petrobas Global Finance

Kingdom of Belgium

Goldgroup Mining

DITN28 - 07/2028

PÃO DE AÇUCAR ON

First Trust Nasdaq Clean...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales